|Bid||7.47 x 800|
|Ask||0.00 x 800|
|Day's Range||10.10 - 10.27|
|52 Week Range||7.48 - 12.09|
|Beta (5Y Monthly)||1.07|
|PE Ratio (TTM)||N/A|
|Earnings Date||Dec 31, 2020 - Jan 04, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||14.00|
In order to justify the effort of selecting individual stocks, it's worth striving to beat the returns from a market...
The company ultimately will be able to reach 90% of the U.S. population, an analyst says, and might resume buybacks and dividend growth in 2021. Also, Wall Street views on Domino’s Pizza, Landec, Walmart, and Paycom Software.
With me on the call today is Dr. Albert Bolles, Landec's Chief Executive Officer; Brian McLaughlin, Landec's Chief Financial Officer; and Jim Hall, President of Lifecore. As a leading innovator in diversified health and wellness solutions, Landec is comprised of two operating businesses, Lifecore Biomedical and Curation Foods. Lifecore Biomedical is a fully integrated contract development and manufacturing organization, or CDMO that offers highly differentiated capabilities in the development, fill and finish of difficult to manufacture pharmaceutical products distributed in syringes and vials.